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Background: No individual trial between XIENCE V everolimus eluting stent (EES) and TAXUS paclitaxel eluting stent (PES) has been adequately 
powered to examine the predictors of stent thrombosis (ST). We therefore analysed ST rates for predictors from a large pooled-database of 4 
randomised trials.
Methods: Baseline clinical, angiographic and procedural data from the SPIRIT II, III, IV and COMPARE trials, each of which randomized patients 
(pts) to EES or PES, were pooled in a database of 6,788 pts. Early (0-30 days), late (30 days-1 yr), very late (1-2 yr) and overall (0-2 yr) definite 
or probable (def/prob) ARC defined ST rates were calculated and Cox proportional hazard regression models were used to identify the baseline 
predictors. Seventeen patient and procedural covariates were analyzed.
Results: Pts with compared to those without def/prob ST were significantly (p<0.05) more younger, active smokers, have hyperlipidemia, prior PCI 
and CABG, NSTEMI at admission, have more stents, lesions, vessels, occlusions, grafts, complex, thrombus and longer lesions treated and less gain 
by QCA. Only active smoking and the use of PES rather than EES were significant predictors of ST during the early, late and very late phases. Table 
shows predictors and rates of def/prob ST in PES and EES.
Conclusions: In this large pooled analysis, active smoking, prior PCI and MI, DM, multivessel treatment and younger age were significant predictors 
for def/prob ST, whereas the use of EES was the major predictor for freedom from ST. 
EES
(n=4247)
HR (95% C.I.) p-value
PES
(n=2541)
HR (95% C.I.) p-value
ST (0-730 d) 0.7% 2.3% 0.30 [0.19,0.47] <0.0001
Predictors Prior PCI 3.99 [ 1.72, 9.28] 0,002 Smoking 2.18 [ 1.24, 3.82] 0,007
DM, all 3.75 [ 1.70, 8.28] 0,002 Prior MI 2.15 [ 1.19, 3.89] 0,02
Prior MI 2.44 [ 1.05, 5.66] 0,04 Stent length 1.14 [ 1.07, 1.21] <0.0001
MV ≥ 2 2.43 [ 1.09, 5.43] 0,03 Age 0.67 [ 0.51, 0.88] 0,004
Early ST 0.2% 1.0% 0.21 [0.10,0.46] <0.0001
Predictors N/A Smoking 2.98 [ 1.34, 6.64] 0,008
Stent length 1.15 [ 1.05, 1.26] 0,004
Late ST 0.2% 0.6% 0.38 [0.17,0.88] 0.02
Predictors Prior PCI 23.71 [ 4.51,124.6] 0,0002 Age 0.40 [ 0.24, 0.68] 0,0007
DM, all 8.09 [ 1.66,39.37] 0,01
Very Late ST 0.3% 0.8% 0.31 [0.14,0.67] 0.002
Predictors Prior PCI 5.88 [ 1.70,20.31] 0,006 Stent length 1.19 [ 1.09, 1.30] 0,0002
Age 0.61 [ 0.39, 0.95] 0,03
